Form D · Biotechnology
Mistral Therapeutics, Inc.
San Diego, CA · CIK 0001520711
Offering snapshot reported Jun 26, 2018 · SEC filing
- Reported sold
- $25.9M Offering amount: $59.3M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2018 | Initial | $25,898,082 | No comparison | 5 | SEC filing |
| Jun 27, 2014 | Amendment | $10,499,999 | $5,499,999vs Jun 21, 2011 | 3 | SEC filing |
| Jun 21, 2011 | Initial | $2,015 | No comparison | 3 | SEC filing |
| Jun 21, 2011 | Initial | $5,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315373
Total Amount Sold includes both cash and amounts paid pursuant to conversion of indebtedness.
Source: Form D, filed Jun 26, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bradley Bolzon | Director |
| Jeremy Caldwell | Executive |
| Thomas A Coll | Executive |
| Jerel Davis | Director |
| Clare Ozawa | Director |
| Petpiboon Prasit | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5871 Oberlin Drive Suite 100
San Diego, CA, 92121
San Diego, CA, 92121